Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
-
Dexcom ONE+ is now available in theUK , incorporating 25 years ofDexcom research to offer a sensor that better meets the needs of those living with diabetes. - Dexcom’s first-ever State of Type 2 Report features survey findings from people with Type 2 diabetes and reveals majority of respondents struggle with anxiety and depression1.
- The ‘Dexcom State of Type 2 Report’ also shows 54% of people wish they could gain more confidence in managing their Type 2 diabetes1.
- CGM usage amongst people with Type 2 diabetes can lead to greater user motivation and improved diabetes management2.
As the
However, the good news for those struggling to manage Type 2 diabetes is that a recent study2 has shown a link between real-time CGM usage, such as Dexcom ONE+, and improved management of the condition. The study showed that by bringing awareness to the impact of food and exercise choices on an individual’s glucose levels, people became more motivated to continue making positive choices, likely leading to significant glycaemic benefits2.
“The Dexcom State of Type 2 report reveals that people trying to manage their Type 2 diabetes face significant impacts on all areas of their lives including, and perhaps particularly, their mental health,” says
About Dexcom ONE+
Dexcom ONE+ incorporates 25 years of
For people managing diabetes using fingerpricks and regularly injecting insulin, their lives can feel overwhelmed by diabetes. Dexcom ONE+ was developed to take away some of this burden, it’s easy to get started with** and is designed to be easy to live with, even for those with no experience of using a CGM system. Like all Dexcom CGM, Dexcom ONE+ gives a clear picture of what glucose levels are doing in real-time, without painful fingerpricks*, therefore making it easier‖ for people to achieve lasting results§,5,‡‡,7,8. Importantly, for loved ones, Dexcom ONE+ also allows a user to easily share their glucose numbers with up to ten people, offering everyone a little more peace of mind††.
Features that set Dexcom ONE+ apart from other CGM systems include multiple possibilities for personalisation and flexibility. Dexcom CGM systems also offer the most discretion, with three wear location options‡ 3,6 and are the only CGM systems to offer a ‘delay first high’ option3§§,a customisable feature which allows a user to set a time before which their sensor will not alert them to a ‘high’ glucose reading, helping to avoid alert fatigue and rebound hypoglycaemia due to over treatment^,9. Furthermore, designed to fit seamlessly into a user’s life, Dexcom ONE+ also has the highest waterproof rating when compared to other CGM brands, allowing users to confidently continue using their device while showering or exercising.
Dexcom ONE+ is suitable for people living with both Type 1 and Type 2, is covered for some people on prescription via the
More on the Dexcom State of Type 2 Report
More than five million people in the
“As the State of Type 2 Report reveals, living with Type 2 diabetes can come with psychological as well as physical challenges,” says Dr.
Specific findings include:
- Understanding at Diagnosis: Just 10% of patients and their caregivers know a lot about Type 2 before diagnosis.
- Mental Health Challenges: Nearly half (42%) of patients and caregivers surveyed said that living with type 2 has negatively impacted their mental health, or that of the person they care for.
- Technological Advancements: While only 9% of patients and caregivers fully understand what a CGM system is – and 70% are unaware it's available on prescription for some people with type 2 – most know that it will help improve their lives with diabetes: in fact, 40% say being able to see glucose numbers in real time and having access to CGM would have the most positive effect on their type 2 diabetes or that of the person they care for.
To read the Dexcom State of Type 2 Report and learn more about how Dexcom ONE+ can benefit you or your loved one, visit dexcom.com/t2report. Dexcom ONE+ will replace the current Dexcom ONE sensor.
Notes to Editors
Additional context, findings, and key highlights from the Dexcom State of Type 2 Report include:
Understanding at Diagnosis: Awareness of type 2 diabetes is low prior to diagnosis, with just 10% of patients knowing a lot about type 2 before diagnosis. Once diagnosed, healthcare practitioners find that patients are most concerned with long-term complications (29%), fear of diabetes related health issues (28%) and how much it will impact their day-to-day lives (27%).
Mental Health Challenges: Living with type 2 diabetes takes a toll on mental health. Nearly half (42%) of patients and caregivers surveyed said that living with type 2 has negatively impacted their mental health, or that of the person they care for. Anxiety (61%) and depression (52%) are the most commonly reported effects of living with type 2.
Balancing Nutrition: Patients and caregivers recognise the importance of proper nutrition to manage type 2, with 81% saying they are aware eating healthily would positively affect their diabetes. Still, there’s room for education and excitement when it comes to eating, with over a quarter (27%) of patients and caregivers agreeing they don’t think they have the right education on food, and 39% saying they find eating after their type 2 diagnosis boring.
Technological Advancements: Technology like CGM makes it easy to manage type 2 diabetes. While only 9% of patients and caregivers fully understand what a CGM system is – and 70% are unaware it's available on prescription for some people with type 2 – most know that it will help improve their lives with diabetes: in fact, 40% say being able to see glucose numbers in real time and having access to CGM would have the most positive effect on their type 2 diabetes or that of the person they care for. Additionally, 83% of patients say if their healthcare team offered them a CGM they would try it.
The Future of Type 2 Diabetes: Sixty-two percent of healthcare practitioners expect the number of patients diagnosed with type 2 diabetes will increase in the next 10 years – with 97% anticipating CGM will become standard practice for caring for patients with type 2 diabetes.1
Will Dexcom ONE+ replace the current Dexcom ONE?
Dexcom ONE+ has been developed based on feedback from consumers and healthcare professionals from the previous generation Dexcom ONE sensor. Patients currently using Dexcom ONE will be transitioned once Dexcom ONE+ is available in their area, so they can benefit from this new and improved generation of
About
Methodology
The research was conducted in
1
† Results obtained with Dexcom G7, which shares the similar features and usability
* If the glucose alerts and readings do not match symptoms a blood glucose meter should be used to make diabetes treatment decisions.
** Compared to previous generation Dexcom CGM System, Dexcom ONE
‖ Compared to Blood Glucose Meter patient use
§ Previous generation Dexcom CGM used, Dexcom ONE+ uses the same sensor as G7
‡‡ Study included non-Dexcom CGM system
‡ Dexcom ONE+ is approved for wear on the arm and abdomen, and children 2-6 years can also wear their sensor on the upper buttocks
The Dexcom ONE+ Sensor is waterproof and may be submerged under 2.4 Meters of water for up to 24 hours without failure when properly installed.
†† Separate Follow app and internet connection required
^ RWE analysis derived from a pseudonymised, aggregated and/or anonymous data set of Dexcom G7 users in the
§§ Not available with Dexcom G6
View source version on businesswire.com: https://www.businesswire.com/news/home/20240520447830/en/
Allison for
Source: